Gene · 4585
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identify the immune characteristics and immunotherapy value of CD93 in the pan-cancer based on the public data sets. | Front Immunol | 2022 | 36389798 | PubTator, text mining | PubMed |
| Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers. | Front Immunol | 2022 | 36389727 | PubTator, text mining | PubMed |
| Low-grade fibromyxoid sarcoma in labial mucosa: Report of a rare case in a pediatric patient. | Oral Oncol | 2022 | 36384080 | PubTator, text mining | PubMed |
| [Salivary papillary cystic low-grade mucoepidermoid carcinoma and cystadenoma: a comparison of clinicopathological and genetic features]. | Zhonghua Kou Qiang Yi Xue Za Zhi | 2022 | 36379892 | PubTator, text mining | PubMed |
| Histochemical Comparison of Human and Rat Lacrimal Glands: Implications for Bio-Engineering Studies. | Transl Vis Sci Technol | 2022 | 36374486 | PubTator, text mining | PubMed |
| Immunopathologic Role of Eosinophils in Eosinophilic Chronic Rhinosinusitis. | Int J Mol Sci | 2022 | 36362100 | PubTator, text mining | PubMed |
| Cluster Analysis of Short Sensory Profile Data Reveals Sensory-Based Subgroups in Autism Spectrum Disorder. | Int J Mol Sci | 2022 | 36361815 | PubTator, text mining | PubMed |
| Integrating Genomic Information with Tumor-Immune Microenvironment in Triple-Negative Breast Cancer. | Int J Environ Res Public Health | 2022 | 36360779 | PubTator, text mining | PubMed |
| The Role of MicroRNAs in HER2-Positive Breast Cancer: Where We Are and Future Prospective. | Cancers (Basel) | 2022 | 36358746 | PubTator, text mining | PubMed |
| Rosai-Dorfman Disease between Proliferation and Neoplasia. | Cancers (Basel) | 2022 | 36358690 | PubTator, text mining | PubMed |
| Viral Integration Plays a Minor Role in the Development and Prognostication of Oral Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 36358632 | PubTator, text mining | PubMed |
| CircRNA-Based Cervical Cancer Prognosis Model, Immunological Validation and Drug Prediction. | Curr Oncol | 2022 | 36354693 | PubTator, text mining | PubMed |
Angioimmunoblastic T-cell lymphoma with extensive follicular dendritic cell and fibroblastic reticular cell network proliferation mimicking follicular dendritic cell sarcoma: A case report with pathologic, immunophenotypic, and molecular findings. | Front Oncol | 2022 | 36353546 | PubTator, text mining | PubMed |
| Common molecular mechanism and immune infiltration patterns of thoracic and abdominal aortic aneurysms. | Front Immunol | 2022 | 36341412 | PubTator, text mining | PubMed |
| Preliminary study on the molecular features of mutation in multiple primary oral cancer by whole exome sequencing. | Front Oncol | 2022 | 36338765 | PubTator, text mining | PubMed |
| Case report and review of literature: Resection of a huge mediastinal low-grade fibromyxoid sarcoma with neck, axillary, and lung involvement. | Front Surg | 2022 | 36338657 | PubTator, text mining | PubMed |
| Radiomics models based on multi-sequence MRI for preoperative evaluation of MUC4 status in pancreatic ductal adenocarcinoma: a preliminary study. | Quant Imaging Med Surg | 2022 | 36330180 | PubTator, text mining | PubMed |
| PKC-mediated phosphorylation and activation of the MEK/ERK pathway as a mechanism of acquired trastuzumab resistance in HER2-positive breast cancer. | Front Endocrinol (Lausanne) | 2022 | 36329884 | PubTator, text mining | PubMed |
| An excipient-free "sugar-coated bullet" for the targeted treatment of orthotopic hepatocellular carcinoma. | Chem Sci | 2022 | 36320701 | PubTator, text mining | PubMed |
| LINC00589-dominated ceRNA networks regulate multiple chemoresistance and cancer stem cell-like properties in HER2+ breast cancer. | NPJ Breast Cancer | 2022 | 36309503 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4585/papers?page=41